EUVIMEDEUVIMED entdecken
Open Access

The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability

Sivaranjani Namasivayam, Matthew Zimmerman, Sandra Oland, Han Wang, Lara R Mittereder, Véronique Dartois iD, Alan Sher

mBio · 2023

DOI: 10.1128/mbio.00353-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2023. Verfasst von Sivaranjani Namasivayam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethes…. Hauptthemen laut MEDLINE: Antitubercular Agents, Tuberculosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, HHS | National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous studies have shown that treatment of Mycobacterium tuberculosis infection with first-line antibiotics results in a long-lasting disruption of the host microbiota. Since the microbiome has been shown to influence the host availability of other drugs, we employed a mouse model to ask whether the dysbiosis resulting from either tuberculosis (TB) chemotherapy or a more aggressive course of broad-spectrum antibiotics might influence the pharmacokinetics of the TB antibiotics themselves.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antitubercular AgentsTuberculosisHumansAnimalsMiceRifampinIsoniazidPyrazinamideBiological AvailabilityMoxifloxacinDysbiosis

Stichwörter der Autor:innen

TBantibioticsmicrobiomepharmacokinetics

Substanzen

Antitubercular AgentsRifampinIsoniazidPyrazinamideMoxifloxacin

Autor:innen und Institutionen

  • Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
  • Hackensack Meridian School of Medicine, Hackensack Meridian Health, Nutley, New Jersey, USA.

ORCID-Profile: Véronique Dartois

Förderung

  • NIH HHS
  • HHS | National Institutes of Health

Zitieren

APA

Namasivayam, S., Zimmerman, M., Oland, S., Wang, H., Mittereder, L. R., Dartois, V., & Sher, A. (2023). The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability. mBio. https://doi.org/10.1128/mbio.00353-23

Vancouver

Namasivayam S, Zimmerman M, Oland S, Wang H, Mittereder LR, Dartois V, et al. The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability. mBio. 2023. doi:10.1128/mbio.00353-23

BibTeX
@article{Namasivayam2023,
  author = {Namasivayam, Sivaranjani and Zimmerman, Matthew and Oland, Sandra and Wang, Han and Mittereder, Lara R and Dartois, Véronique and Sher, Alan},
  title = {The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability},
  journal = {mBio},
  year = {2023},
  doi = {10.1128/mbio.00353-23}
}
Kostenlos starten →